Xact Kapitalforvaltning AB Invests $220,000 in Healthequity Inc (HQY) Stock

Xact Kapitalforvaltning AB acquired a new position in Healthequity Inc (NASDAQ:HQY) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 4,716 shares of the company’s stock, valued at approximately $220,000.

A number of other institutional investors have also recently bought and sold shares of HQY. New York State Common Retirement Fund boosted its stake in shares of Healthequity by 13.5% during the 3rd quarter. New York State Common Retirement Fund now owns 180,718 shares of the company’s stock valued at $9,141,000 after buying an additional 21,441 shares during the period. Legal & General Group Plc boosted its stake in shares of Healthequity by 15.2% during the 3rd quarter. Legal & General Group Plc now owns 100,891 shares of the company’s stock valued at $5,100,000 after buying an additional 13,350 shares during the period. Schwab Charles Investment Management Inc. boosted its stake in shares of Healthequity by 13.7% during the 3rd quarter. Schwab Charles Investment Management Inc. now owns 225,389 shares of the company’s stock valued at $11,401,000 after buying an additional 27,073 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of Healthequity by 12.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 531,288 shares of the company’s stock valued at $26,872,000 after buying an additional 57,855 shares during the period. Finally, Envestnet Asset Management Inc. acquired a new stake in shares of Healthequity during the 3rd quarter valued at $273,000. 99.17% of the stock is owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

A number of equities research analysts have issued reports on the stock. KeyCorp lifted their target price on shares of Healthequity from $66.00 to $72.00 and gave the company an “overweight” rating in a research note on Thursday, April 5th. Zacks Investment Research lowered shares of Healthequity from a “buy” rating to a “hold” rating in a research note on Wednesday, April 4th. ValuEngine raised shares of Healthequity from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $65.00 price objective on shares of Healthequity in a research note on Friday, March 23rd. Finally, Barrington Research lifted their price objective on shares of Healthequity to $65.00 and gave the company an “outperform” rating in a research note on Tuesday, March 20th. Two equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Healthequity presently has an average rating of “Buy” and a consensus target price of $66.50.

In related news, insider Jon Kessler sold 40,000 shares of Healthequity stock in a transaction on Thursday, January 25th. The shares were sold at an average price of $49.47, for a total value of $1,978,800.00. Following the transaction, the insider now owns 485,000 shares in the company, valued at approximately $23,992,950. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Darcy G. Mott sold 9,500 shares of Healthequity stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $48.00, for a total transaction of $456,000.00. Following the completion of the transaction, the vice president now owns 99,500 shares in the company, valued at approximately $4,776,000. The disclosure for this sale can be found here. Insiders sold a total of 750,831 shares of company stock worth $40,420,618 in the last quarter. Insiders own 19.00% of the company’s stock.

HQY stock opened at $65.91 on Wednesday. Healthequity Inc has a 1 year low of $40.21 and a 1 year high of $68.75. The firm has a market capitalization of $3,913.12, a P/E ratio of 93.04, a price-to-earnings-growth ratio of 2.57 and a beta of 1.39.

Healthequity (NASDAQ:HQY) last released its quarterly earnings data on Monday, March 19th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.06. The business had revenue of $60.44 million during the quarter, compared to analyst estimates of $58.46 million. Healthequity had a net margin of 20.64% and a return on equity of 13.47%. research analysts forecast that Healthequity Inc will post 0.77 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This story was first posted by Week Herald and is the property of of Week Herald. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://weekherald.com/2018/04/18/xact-kapitalforvaltning-ab-invests-220000-in-healthequity-inc-hqy-stock.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply